Vanguard Group
BNGO icon

Vanguard Group’s Bionano Genomics BNGO Stock Holding History

Vanguard Group’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$126K Buy
82,307
+31,848
+63% +$55.1K ﹤0.01% 4151
2025
Q3 		$86.3K Buy
+50,459
New +$160K ﹤0.01% 4244
2025
Q2 		– Sell
-49,979
Closed -$139K – 4283
2025
Q1 		$139K Buy
49,979
+18,644
+59% +$122K ﹤0.01% 4105
2024
Q4 		$541K Sell
31,335
-5,207
-14% -$89K ﹤0.01% 3927
2024
Q3 		$995K Buy
36,542
+1,709
+5% +$53.2K ﹤0.01% 3776
2024
Q2 		$1.42M Buy
34,833
+3,254
+10% +$179K ﹤0.01% 3674
2024
Q1 		$2.1M Buy
31,579
+18
+0.1% +$1.34K ﹤0.01% 3573
2023
Q4 		$3.58M Buy
31,561
+6,667
+27% +$696K ﹤0.01% 3405
2023
Q3 		$4.53M Buy
24,894
+699
+3% +$183K ﹤0.01% 3294
2023
Q2 		$8.86M Sell
24,195
-3,157
-12% -$1.43M ﹤0.01% 3016
2023
Q1 		$18.2M Buy
27,352
+578
+2% +$513K ﹤0.01% 2626
2022
Q4 		$23.5M Buy
26,774
+533
+2% +$671K ﹤0.01% 2546
2022
Q3 		$28.8M Buy
26,241
+184
+0.7% +$243K ﹤0.01% 2462
2022
Q2 		$21.6M Sell
26,057
-403
-2% -$415K ﹤0.01% 2605
2022
Q1 		$41M Buy
26,460
+1,751
+7% +$2.36M ﹤0.01% 2400
2021
Q4 		$44.3M Sell
24,709
-380
-2% -$1.02M ﹤0.01% 2418
2021
Q3 		$82.8M Buy
25,089
+330
+1% +$1.15M ﹤0.01% 2086
2021
Q2 		$109M Buy
24,759
+9,266
+60% +$36.6M ﹤0.01% 1959
2021
Q1 		$75.1M Buy
15,493
+3,605
+30% +$20.3M ﹤0.01% 2102
2020
Q4 		$22M Buy
11,888
+2,611
+28% +$976K ﹤0.01% 2596
2020
Q3 		$3.62M Buy
9,277
+8,686
+1,470% +$3.37M ﹤0.01% 3299
2020
Q2 		$181K Buy
591
+255
+76% +$64K ﹤0.01% 3934
2020
Q1 		$92K Buy
+336
New +$190K ﹤0.01% 3955

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RS
R Squared Central, Hong Kong $190M AUM 25.89% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return

Vanguard Group's BNGO Position: Q4 2025 in Review

Vanguard Group increased its Bionano Genomics (BNGO) stake by 63% in Q4 2025, buying an estimated $55.1K and bringing the position to 82,307 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #4151.

Vanguard Group first reported a position in BNGO in Q1 2020 and has held it in 23 quarters since. The position peaked at $109M in Q2 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q4 2025.

  • Vanguard Group held 82,307 shares of Bionano Genomics worth $126K as of Q4 2025.
  • Vanguard Group bought 31,848 Bionano Genomics shares in Q4 2025, an estimated $55.1K.
  • Bionano Genomics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4151 holding.
  • Vanguard Group first reported a position in Bionano Genomics in Q1 2020 and has held it in 23 quarters since.
  • Vanguard Group's Bionano Genomics position peaked at $109M in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.